Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1948 1
1949 1
1950 1
1958 1
1960 2
1962 6
1964 1
1965 2
1966 3
1967 5
1968 4
1969 7
1970 10
1971 12
1972 15
1973 17
1974 7
1975 11
1976 8
1977 24
1978 15
1979 15
1980 13
1981 13
1982 19
1983 25
1984 29
1985 40
1986 42
1987 50
1988 55
1989 74
1990 68
1991 70
1992 83
1993 118
1994 102
1995 147
1996 166
1997 206
1998 258
1999 310
2000 484
2001 469
2002 579
2003 662
2004 849
2005 997
2006 1151
2007 1449
2008 1763
2009 2068
2010 2444
2011 2965
2012 3248
2013 3497
2014 3677
2015 3793
2016 3845
2017 4059
2018 4220
2019 4367
2020 1343
Text availability
Article attribute
Article type
Publication date

Search Results

44,380 results
Results by year
Filters applied: . Clear all
Page 1
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Zhong B, Stuyckens K, Santiago-Walker A, De Porre P, O'Hagan A, Avadhani A, Siefker-Radtke AO; BLC2001 Study Group. Loriot Y, et al. Among authors: Park SH. N Engl J Med. 2019 Jul 25;381(4):338-348. doi: 10.1056/NEJMoa1817323. N Engl J Med. 2019. PMID: 31340094 Clinical Trial.
The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ. Lim J, et al. Among authors: Park SJ. J Korean Med Sci. 2020 Feb 24;35(7):e89. doi: 10.3346/jkms.2020.35.e89. J Korean Med Sci. 2020. PMID: 32080993 Free article. No abstract available.
Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR.
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ. Lim J, et al. Among authors: Park SJ. J Korean Med Sci. 2020 Feb 17;35(6):e79. doi: 10.3346/jkms.2020.35.e79. J Korean Med Sci. 2020. PMID: 32056407 Free PMC article.
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes.
Whitworth J, Smith PS, Martin JE, West H, Luchetti A, Rodger F, Clark G, Carss K, Stephens J, Stirrups K, Penkett C, Mapeta R, Ashford S, Megy K, Shakeel H, Ahmed M, Adlard J, Barwell J, Brewer C, Casey RT, Armstrong R, Cole T, Evans DG, Fostira F, Greenhalgh L, Hanson H, Henderson A, Hoffman J, Izatt L, Kumar A, Kwong A, Lalloo F, Ong KR, Paterson J, Park SM, Chen-Shtoyerman R, Searle C, Side L, Skytte AB, Snape K, Woodward ER; NIHR BioResource Rare Diseases Consortium, Tischkowitz MD, Maher ER. Whitworth J, et al. Among authors: Park SM. Am J Hum Genet. 2018 Jul 5;103(1):3-18. doi: 10.1016/j.ajhg.2018.04.013. Epub 2018 Jun 14. Am J Hum Genet. 2018. PMID: 29909963 Free PMC article.
17(S),18(R)-epoxyeicosatetraenoic acid generated by cytochrome P450 BM-3 from Bacillus megaterium inhibits the development of contact hypersensitivity via G-protein-coupled receptor 40-mediated neutrophil suppression.
Saika A, Nagatake T, Kishino S, Park SB, Honda T, Matsumoto N, Shimojou M, Morimoto S, Tiwari P, Node E, Hirata SI, Hosomi K, Kabashima K, Ogawa J, Kunisawa J. Saika A, et al. Among authors: Park SB. FASEB Bioadv. 2019 Dec 24;2(1):59-71. doi: 10.1096/fba.2019-00061. eCollection 2020 Jan. FASEB Bioadv. 2019. PMID: 32123857 Free PMC article.
Trial of everolimus-eluting stents or bypass surgery for coronary disease.
Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK; BEST Trial Investigators. Park SJ, et al. Among authors: Park DW, Park SW. N Engl J Med. 2015 Mar 26;372(13):1204-12. doi: 10.1056/NEJMoa1415447. Epub 2015 Mar 16. N Engl J Med. 2015. PMID: 25774645 Free article. Clinical Trial.
Retraction: Inhibition of HMGB1-Induced Angiogenesis by Cilostazol via SIRT1 Activation in Synovial Fibroblasts from Rheumatoid Arthritis.
Kim HY, Park SY, Lee SW, Lee HR, Lee WS, Rhim BY, Hong KW, Kim CD. Kim HY, et al. Among authors: Park SY. PLoS One. 2020 Mar 19;15(3):e0230889. doi: 10.1371/journal.pone.0230889. eCollection 2020. PLoS One. 2020. PMID: 32191778 Free PMC article. No abstract available.
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.
Kang E, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW; Korean Hereditary Breast Cancer Study Group. Kang E, et al. Among authors: Park SK. Breast Cancer Res Treat. 2015 May;151(1):157-68. doi: 10.1007/s10549-015-3377-4. Epub 2015 Apr 12. Breast Cancer Res Treat. 2015. PMID: 25863477
Reply.
Choi S, Park SM, Jahng WJ, Jee D. Choi S, et al. Among authors: Park SM. Am J Ophthalmol. 2020 Mar 12:S0002-9394(20)30039-8. doi: 10.1016/j.ajo.2020.01.030. Online ahead of print. Am J Ophthalmol. 2020. PMID: 32172928 No abstract available.
44,380 results
Jump to page
Feedback